Anthrax nasal vaccine, NasoShield, being developed by team led by Texas A&M
by Press Release from Outbreak News Today on (#1DBWW)
For the first time, one of the nation's Centers for Innovation in Advanced Development and Manufacturing (CIADM) will support development of a second-generation anthrax vaccine under a task order issued by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR). The CIADM led by the Texas ["]
